Market Place
Sourcing Support
All News #Library
Biotech
Cabaletta Bio, Cellares Ink 10-Year Supply Deal For Rese-Cel
28 Apr 2026 //
GLOBENEWSWIRE
Cabaletta Bio Doses First Patients with Rese-cel from Cellares
14 Apr 2026 //
PHARMIWEB
Cellares, UW Expand CRISPR CAR-T Partnership
18 Feb 2026 //
BUSINESSWIRE
Cellares Expands Automation for Gene-Edited Stem Cell Therapies
03 Feb 2026 //
BUSINESSWIRE
Cellares Establishes European HQ in the Netherlands
12 Jan 2026 //
BUSINESSWIRE
Cabaletta Bio Clears IND Amendment For Rese-Cel Manufacturing
12 Jan 2026 //
PHARMIWEB
Cellares, City of Hope Automate Solid Tumor Manufacturing
08 Jan 2026 //
BUSINESSWIRE
Autolus to Test Automated AUCATZYL Manufacturing With Cellares
06 Jan 2026 //
BUSINESSWIRE
Slingshot and Cellares Partner to Boost Cell Therapy Automation
28 Oct 2025 //
BUSINESSWIRE
Cellares Selects Five Providers To Expand Cell Q Capabilities
17 Sep 2025 //
PHARMAWEB
Cellares, Mitsui Launch First IDMO Smart Cell Factory in Japan
29 May 2025 //
BUSINESSWIRE
Cellares to Automate CRISPR-Edited CAR-T for Tumors
10 Apr 2025 //
BUSINESSWIRE
Cellares` Cell Shuttle™ gets FDA AMT Designation for Cell Therapy
01 Apr 2025 //
BUSINESSWIRE
Cellares, Cabaletta Bio Complete Rese-cel Manufacturing Program
19 Mar 2025 //
BUSINESSWIRE
Cellares And Sony Partner On Cell Therapy Manufacturing Platform
12 Sep 2024 //
BUSINESSWIRE
BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement
23 Apr 2024 //
PRESS RELEASE
Cell therapy manufacturer Cellares gains 1st cGMP certification
12 Mar 2024 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.